Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Understanding the relationship between cognitive performance and function in daily life after traumatic brain injury

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Magnetic resonance imaging at baseline and follow-up to differentiate between pediatric monophasic acquired CNS demyelination and MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: To assess the risk of losing income from salaries and risk disability pension for multiple sclerosis patients with a clinically stable disease course 3 years after the start of disease-modifying therapy (DMT).

METHODS: Data from the Danish Multiple Sclerosis Registry were linked to other Danish nationwide population-based databases. We included patients who started treatment with a DMT between 2001 and 2014. Patients were categorised into a clinically stable group (No Evidence of Disease Activity (NEDA-2)) and a clinically active group (relapse activity or 6-month confirmed Expanded Disability Status Scale worsening). Outcomes were: (1) loss of regular income from salaries and (2) a transfer payment labelled as disability pension. We used a Cox proportional hazards model to estimate confounder-adjusted HRs, and absolute risks were plotted using cumulative incidence curves accounting for competing risks.

RESULTS: We included 2406 patients for the income analyses and 3123 patients for the disability pension analysis. Median follow-up from index date was ~5 years in both analyses. The NEDA-2 group had a 26% reduced rate of losing income (HR 0.74; 95% CI 0.60 to 0.92). HRs were calculated for 5-year intervals in the disability pension analysis: year 0-5: a 57% reduced rate of disability pension for the NEDA-2 group (HR 0.43; 95% CI 0.33 to 0.55) and year 5-10: a 36% reduced rate (HR 0.64; 95% CI 0.40 to 1.01).

CONCLUSION: Clinically stable disease course (NEDA-2) is associated with a reduced risk of losing income from salaries and a reduced risk of disability pension.

Original languageEnglish
JournalJournal of neurology, neurosurgery, and psychiatry
Volume91
Issue number1
Pages (from-to)67-74
Number of pages8
ISSN0022-3050
DOIs
Publication statusPublished - Jan 2020

    Research areas

  • Adolescent, Adult, Databases, Factual, Denmark/epidemiology, Disability Evaluation, Disease Progression, Endpoint Determination, Female, Humans, Income, Male, Middle Aged, Multiple Sclerosis/economics, Pensions/statistics & numerical data, Recurrence, Registries, Risk Assessment, Salaries and Fringe Benefits, Young Adult

ID: 61515844